Thu 25 Jun 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia | Janssen-Cilag International NV | Ongoing | Consta | 4 | RRA-19315 | Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar) |
| The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study | King Faisal Specialist Hospital & Research Center | Ongoing | Tigecycline | 4 | RAC#216103 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial | Sunnybrook Health Sience Center / KAIMRC | Ongoing | All SFDA already registered Antibiotics | 4 | CT 15/022 | King Abdulaziz Medical City NG (Riyadh) |
| ChaRactErization of patients following aCute venous thrOmboembolism (VTE) and assessment of safety and effectiveness of dabigatran etexilate (DE) in the tReatment and secondarY prevention of acute deep vein thrombosis (DVT) and pulmonary embolism (PE) in comparison to vitamin K antagonist (VKA) in routine clinical practice - RE-COVERY DVT/PE | Boehringer Ingelheim | Ongoing | Dabigatran etexilate | 4 | 1160.188 | King Salman Bin AbdulAziz Hospital |
| Forxiga (dapagliflozin) Post Authorization Safety Study | AstraZeneca | Ongoing | Forxiga | 4 | D1690R0003 | King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| A Multicenter, prospective, non-interventional study to assess Adherence to treatment for patIeNts with Relapsing Multiple Sclerosis (RMS) who are prescribed subcutaneous (sc) interferon beta-1a | Merck Serono | Ongoing | Interferon Beta-1 a (Rebif) | 4 | MS200136_0 | King Fahad Specialist Hospital (Dammam), King Khalid University Hospital (Riyadh), King Fahad University Hospital (Al-Khobar), King Faisal Specialist Hospital and Research Center (Jeddah) |
| "CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions" | Novartis | Ongoing | Cosyntex | 4 | IN457A3404 | King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah) |
| Does the Addition of Proton Pump Inhibitors to Continuous Enteral Feeding Provide Added Protection Against Upper GI Bleeding in Acutely Ill Patients | KAIMRC | Ongoing | Esmoprozol | 4 | RC15/079 | King Abdulaziz Medical City NG (Riyadh) |
| Real World retrospective study of effectiveness and safety of Gilenya (FINgOlimod) in relapsing remitting Multiple Sclerosis in the Middle East and North Africa (FINOMENA) | Novartis | Ongoing | Fingolimod | 4 | TY720DAE01 | King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Hospital (Jeddah), King Abdulaziz Hospital Oncology Center, King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), Hira Hospital (Makkah), King Fahad Specialist Hospital (Dammam), Dr. Erfan & Bagedo General Hospital (Jeddah) |
| A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis | Novartis | Ongoing | ofatumumab | 3 | COMB157G2301 | King Faisal Specialist Hospital and Research Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.